e-Article
Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial
Document Type
Artikel
Author
Source
Journal of the American Academy of Dermatology. 89(3):486-495
Subject
Language
English
English
English
ISSN
1097-6787